Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel A Piris

Showing results (131-140 of 231) with videos related to

Pageof 24
Sort By:
British Journal of Haematology|December 19, 2014
Long-term follow-up of dose-adjusted EPOCH plus rituximab (DA-EPOCH-R) in untreated patients with poor prognosis large B-cell lymphoma. A phase II study conducted by the Spanish PETHEMA GroupNoelia Purroy, Juan Bergua, Laura Gallur, et al.
Blood|June 16, 2012
Heterozygosity for Roquinsan leads to angioimmunoblastic T-cell lymphoma-like tumors in miceJulia I Ellyard, Tiongsun Chia, Socorro-Maria Rodriguez-Pinilla, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 30, 2008
TCL1A expression delineates biological and clinical variability in B-cell lymphomaMohit Aggarwal, Raquel Villuendas, Gonzalo Gomez, et al.
Blood|August 9, 2013
Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphomaPaola Bonetti, Monica Testoni, Marta Scandurra, et al.
The American Journal of Pathology|January 27, 2004
Building an outcome predictor model for diffuse large B-cell lymphomaAna-Isabel Sáez, Antonio-José Sáez, María-Jesús Artiga, et al.
Haematologica|March 9, 2010
The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivationTeresa Marafioti, Jennifer C Paterson, Erica Ballabio, et al.
Scientific Reports|February 1, 2019
Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemiaJulia González-Rincón, Sagrario Gómez, Nerea Martinez, et al.
Oncotarget|January 18, 2018
Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targetsElena Mata, Antonio Díaz-López, Ana M Martín-Moreno, et al.
Nature Medicine|November 14, 2017
Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignanciesPaul M Maciocia, Patrycja A Wawrzyniecka, Brian Philip, et al.
Leukemia & Lymphoma|June 27, 2013
Simplification of risk stratification for splenic marginal zone lymphoma: a point-based score for practical useCarlos Montalban, Victor Abraira, Luca Arcaini, et al.
Pageof 24

Showing results (131-140 of 231) with videos related to

Sort By:
Pageof 24
British Journal of Haematology|December 19, 2014
Long-term follow-up of dose-adjusted EPOCH plus rituximab (DA-EPOCH-R) in untreated patients with poor prognosis large B-cell lymphoma. A phase II study conducted by the Spanish PETHEMA GroupNoelia Purroy, Juan Bergua, Laura Gallur, et al.
Blood|June 16, 2012
Heterozygosity for Roquinsan leads to angioimmunoblastic T-cell lymphoma-like tumors in miceJulia I Ellyard, Tiongsun Chia, Socorro-Maria Rodriguez-Pinilla, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 30, 2008
TCL1A expression delineates biological and clinical variability in B-cell lymphomaMohit Aggarwal, Raquel Villuendas, Gonzalo Gomez, et al.
Blood|August 9, 2013
Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphomaPaola Bonetti, Monica Testoni, Marta Scandurra, et al.
The American Journal of Pathology|January 27, 2004
Building an outcome predictor model for diffuse large B-cell lymphomaAna-Isabel Sáez, Antonio-José Sáez, María-Jesús Artiga, et al.
Haematologica|March 9, 2010
The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivationTeresa Marafioti, Jennifer C Paterson, Erica Ballabio, et al.
Scientific Reports|February 1, 2019
Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemiaJulia González-Rincón, Sagrario Gómez, Nerea Martinez, et al.
Oncotarget|January 18, 2018
Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targetsElena Mata, Antonio Díaz-López, Ana M Martín-Moreno, et al.
Nature Medicine|November 14, 2017
Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignanciesPaul M Maciocia, Patrycja A Wawrzyniecka, Brian Philip, et al.
Leukemia & Lymphoma|June 27, 2013
Simplification of risk stratification for splenic marginal zone lymphoma: a point-based score for practical useCarlos Montalban, Victor Abraira, Luca Arcaini, et al.
Pageof 24